Novartis, a leading Switzerland based multinational pharma company, has informed that it has linked up with USV, a leading healthcare company to sell its anti- diabetic product Galvus in India.
According to the sources, the tie up with USV is a part of Novartis plans to pitch its proposed product against Merck's Januvia by pricing it lower - in the Indian anti-diabetic market which saw total sales of Rs 1,672 crore till June 2008.
The internet provided a kaleidoscopic view of happenings in Mumbai from the time the first shots were fired.
Through blogs and file-sharing websites, those held up in the turmoil rapidly provided accounts from the ground plus links to the best news reports appearing on the web.
One rich source of information was ‘Twitter’ that offers text-message-length information . Its Mumbai thread provided a stream of clips, not all precise, from observers on the ground, with some details of deaths, military blockade, clashes, and even the suspected names of terrorists.
IGNOU (Indira Gandhi National Open University) has informed that it intends to build 650 examination centres across the country, including 15 in various jails, for its ensuing 'term-end examination' commencing December1.
"More than 2.73 lakh candidates will appear for the examinations," IGNOU spokesperson Ravi Mohan said.
According to the sources, IGNOU has also established 15 examination centres in jails for inmates who have enrolled to its various undergraduate courses.
Leader of the Opposition L K Advani spoke to Prime Minister Manmohan Singh on Wednesday night after the terrorist attack in Mumbai. The PM confirmed him that terrorists had attacked at five places in which at least 18 people were killed and 25 injured.
Advani called up Singh twice to find out details of the terror strikes in Mumbai.
The Prime Minister told Advani that incidents, including a bomb blast and firing, had taken place at five places across the commercial capital and 18 people had died while 25 had been injured in these attacks.